Chunlong L. Zhong
160 Pujian Road
Shanghai, 200127, China
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
A New Fluorine-18-Fluoroethyltyrosine Positron-Emission-Tomography/Magnetic-Resonance-Based Tumor Resection Plan Improved the Prognosis of Glioblastoma Patients. A Multicenter Validated Study.
Journal: Research (Washington, D.C.)
Published: March 19, 2026
Safety and efficacy of decompressive craniectomy versus standard craniotomy for large acute epidural haematoma with tentorial herniation in China (PREDICT-AEDH): a nationwide, multicentre, open-label, parallel-group, randomised controlled trial.
Journal: The Lancet. Neurology
Published: February 02, 2026
Lactate-Induced K370 Lactylation of STING Inhibits STING-TBK1 Signaling and Dampens Anti-Tumor Immunity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 13, 2026
Disrupting MED8-dependent epigenetic reprogramming augments avapritinib sensitivity in PDGFRA-driven glioma.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 22, 2025
Development and validation of a customised PRO-CTCAE scale for adult-type diffuse gliomas (VERONICA): a multicentre, prospective, observational cohort study in China.
Journal: EClinicalMedicine
Published: September 26, 2025
Clostridium butyricum Restores Intestinal Barrier Integrity via the IL-22/Reg3 Pathway Following Traumatic Brain Injury in Mice.
Journal: Journal of neurotrauma
Published: August 29, 2025
Loss of EPB41L3: a common molecular link in the tumorigenesis of neurofibromatosis types 1 and 2.
Journal: Frontiers in oncology
Published: May 29, 2025
Multiple patient-derived glioblastoma models reveal synthetic lethality through concurrent PI3K and CDK4/6 inhibition by blocking trans-active cooperation.
Journal: Neuro-oncology
Published: May 09, 2025
Combined inhibition of WEE1 by AZD1775 synergistically enhances CX-5461 mediated DNA damage and induces cytotoxicity in glioblastoma.
Journal: Tissue & cell
Published: May 06, 2025
Co-activation of the super-enhancer complex SOX2 and HDAC1 confers temozolomide resistance by promoting PDGFB transcription in glioblastoma.
Journal: Neuro-oncology
Published: May 04, 2025
Glioma drug development benefits from emerging phase 0 and window-of-opportunity trial paradigm.
Journal: Cell communication and signaling : CCS
Published: March 01, 2025
YTHDF3 facilitates DNA damage response by recognizing METTL3-mediated m6A modification to promote chemotherapy resistance in glioblastoma.
Journal: Cancer letters
Published: November 29, 2024
Last Updated: 09/26/2026